Heart patients may ditch blood thinners after ablation, major trial investigates

NCT ID NCT06871228

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people with atrial fibrillation (AF) can safely stop taking blood thinners after a successful heart ablation procedure. About 4,100 adults aged 18-80 who have been on blood thinners for at least 2 months after ablation and have no signs of AF recurrence will be randomly assigned to either stop or continue their medication. All participants will use smartwatches and regular heart monitors to catch any return of AF. The goal is to see if stopping blood thinners reduces bleeding risks without increasing the chance of stroke or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation Hemorrhage Thromboembolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Anzhen Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

  • Chengdu Fifth People's Hospital

    NOT_YET_RECRUITING

    Chengdu, Sichuan, 611130, China

  • First Affiliated Hospital of Dalian Medical University

    NOT_YET_RECRUITING

    Dalian, Liaoning, 116023, China

  • Guangdong Provincial People's Hospital

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510080, China

  • Henan Provincial Chest Hospital

    NOT_YET_RECRUITING

    Zhengzhou, Henan, 450003, China

  • Liaocheng Heart Hospital

    NOT_YET_RECRUITING

    Liaocheng, Shandong, 252299, China

  • Liaocheng People's Hospital

    NOT_YET_RECRUITING

    Liaocheng, Shandong, 252000, China

  • Luohe Central Hospital

    NOT_YET_RECRUITING

    Luohe, Henan, 462003, China

  • Ningbo No.2 Hospital

    NOT_YET_RECRUITING

    Ningbo, Zhejiang, 315000, China

  • Qilu Hospital of Shandong University

    NOT_YET_RECRUITING

    Jinan, Shandong, 250012, China

  • Shengjing Hospital Affiliated to China Medical University

    NOT_YET_RECRUITING

    Shenyang, Liaoning, 110004, China

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310009, China

  • The Affiliated Hospital of Xuzhou Medical University

    NOT_YET_RECRUITING

    Xuzhou, Jiangsu, 221002, China

  • The First Affiliated Hospital of Anhui Medical University

    NOT_YET_RECRUITING

    Hefei, Anhui, 230022, China

  • The First Affiliated Hospital of Harbin Medical University

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, 150001, China

  • The First Affiliated Hospital of Nanjing Medical University

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210036, China

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310000, China

  • The First Hospital of Jilin University

    NOT_YET_RECRUITING

    Changchun, Jilin, 130021, China

  • The Second Affiliated Hospital of Harbin Medical University

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, 150085, China

  • The Second Hospital of Hebei Medical University

    NOT_YET_RECRUITING

    Shijiazhuang, Hebei, 050000, China

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430030, China

  • Wuhan Asia Heart Hospital

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.